(Q36713971)

15 August 2017

1 reference

title

Cannabis use and the risk of developing a psychotic disorder (English)

1 reference

15 August 2017

1 reference

2

Louisa Degenhardt

0 references

author name string

Wayne Hall

series ordinal

1

1 reference

PMC publication ID

2424288

15 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

15 August 2017

1 reference

15 August 2017

7

1 reference

15 August 2017

2

1 reference

15 August 2017

68-71

1 reference

Management of persons with co-occurring severe mental illness and substance use disorder: program implications.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Changing incidence of psychotic disorders among the young in Zurich

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

What are the policy implications of the evidence on cannabis and psychosis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Causal relationship between cannabis use and psychotic symptoms or depression. Should we wait and see? A public health perspective.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use and mental health in young people: cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

How does drug and alcohol misuse develop among people with psychotic illness? A literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

The role of cannabinoids in neurodegenerative diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use and psychosis: a review of clinical and epidemiological evidence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Addiction and schizophrenia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Substance use disorders in schizophrenia: review, integration, and a proposed model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Dual diagnosis: a review of etiological theories

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis and psychosis. Is there epidemiological evidence for an association?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Comorbidity of schizophrenia and substance abuse: implications for treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use and psychosis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Testing hypotheses about the relationship between cannabis use and psychosis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis dependence and psychotic symptoms in young people

5 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

5 September 2018

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Are cannabinoid receptor knockout mice animal models for schizophrenia?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Cannabis use is associated with schizotypy and attentional disinhibition.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

Drug abuse in a young psychiatric population

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2424288

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

5 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

Treatment programmes for people with both severe mental illness and substance misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

The mental health risks of adolescent cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

Cannabis use and outcome of recent onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.2051-5545.2008.TB00158.X

Cannabis abuse and the course of recent-onset schizophrenic disorders

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18560513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Elevated endogenous cannabinoids in schizophrenia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18560513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Is the grass greener? The link between cannabis and psychosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18560513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/J.2051-5545.2008.TB00158.X

1 reference

15 August 2017

1 reference

PMC publication ID

2424288

15 August 2017

PubMed publication ID

18560513

1 reference

PMC publication ID

2424288